Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Cerilliant
Medtronic
Harvard Business School
Federal Trade Commission
Cantor Fitzgerald
Healthtrust
Dow
Argus Health
Chinese Patent Office

Generated: October 23, 2017

DrugPatentWatch Database Preview

Ibuprofen lysine - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen lysine and what is the scope of ibuprofen lysine freedom to operate?

Ibuprofen lysine
is the generic ingredient in two branded drugs marketed by Exela Pharma Science and Recordati Rare, and is included in two NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ibuprofen lysine has twelve patent family members in six countries.

There are sixty-four drug master file entries for ibuprofen lysine. Three suppliers are listed for this compound.

Summary for Generic Name: ibuprofen lysine

US Patents:3
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list64
Suppliers / Packagers: see list3
Clinical Trials: see list588
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ibuprofen lysine at DailyMed

Pharmacology for Ingredient: ibuprofen lysine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes► Subscribe► SubscribeYY ► Subscribe
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes► Subscribe► SubscribeYYY ► Subscribe
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes► Subscribe► SubscribeY ► Subscribe
Exela Pharma Science
IBUPROFEN LYSINE
ibuprofen lysine
INJECTABLE;INTRAVENOUS202402-001Mar 30, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen lysine

Country Document Number Estimated Expiration
Japan2002326929► Subscribe
Canada2361160► Subscribe
Austria318136► Subscribe
Germany60209269► Subscribe
European Patent Office1205181► Subscribe
European Patent Office1249234► Subscribe
Canada2377453► Subscribe
Germany60110185► Subscribe
MexicoPA01011629► Subscribe
Austria293444► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Citi
Healthtrust
Queensland Health
Moodys
QuintilesIMS
Baxter
Fish and Richardson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot